drugset / Trial / NCT04101838

B Cell and Antibody Response to Seasonal Influenza Vaccines in Younger and Older Adults

NCT04101838

Phase 4 Active not recruiting 50 enrolled University of Alabama at Birmingham
RandomizedParallel-groupSingle-blindBasic science

Summary

This study will examine how various FDA-approved seasonal influenza vaccine types, used in a manner consistent with their approved use, impact the characteristics of influenza specific antibodies in humans, and how these responses differ based on age and prior immunization history.

Timeline

Start
2021-04-01
Primary completion
2026-05-11
Completion
2027-05

Drugs

EvaluationDrugModalityDoseRoute
Comparator Fluad Vaccine
Comparator Flucelvax Vaccine
Comparator Influenza Virus Vaccine Vaccine

Indications